医学
受益人
精算学
健康与退休研究
环境卫生
老年学
财务
经济
作者
Julia Cave Arbanas,Cheryl L. Damberg,Mei Leng,Nina T. Harawa,Catherine A. Sarkisian,Bruce E. Landon,John N. Mafi
标识
DOI:10.1001/jamainternmed.2023.1749
摘要
This cross-sectional cost analysis uses data from the 2018 Health and Retirement Study to estimate the potential future Medicare spending and beneficiary costs for lecanemab.
科研通智能强力驱动
Strongly Powered by AbleSci AI